Biotech

All Articles

Gene publisher Volume giving up 131 laborers

.Merely days after gene editor Tome Biosciences declared undisclosed working cuts, a clearer image i...

Repare lays off 25% of staff as biotech halts preclinical R&ampD

.Repare Therapeutics is laying off an one-fourth of its own labor force as the oncology biotech scal...

J &amp J files for FDA approval of $6.5 B autoimmune medicine

.Johnson &amp Johnson has actually taken an additional action towards noticing a profit on its $6.5 ...

Gain's phase 1 win paves way to confirm Parkinson's medicine's worth

.Increase Therapies has actually set its own sights on showing the effectiveness of its own Parkinso...

Actinogen files brand new phase 2 records to restore anxiety medicine

.Actinogen Medical's hopes-- and inventory rate-- have recoiled a little coming from previously this...

Pfizer as well as Crown jewel incorporate Quotient to multibillion-dollar equation

.Flagship Pioneering and also Pfizer have incorporated Quotient into their 10-program partnership, i...

Bayer markers $547M pact to press limits of noncoding RNA

.Bayer executives were actually eager to stress to Intense this summertime that the German pharma ti...

UK reveals strategies to launch 18 new professional test hubs

.Surrounded by a yearslong medical trial decrease in the U.K., a new public-private alliance has act...

UPDATE: Genentech telegraphs 93 discharges in California after discussing programs to shutter cancer cells immunology study unit

.Following the news of a large cutback round in April as well as a major rebuilding effort introduce...

Neurocrine's KarXT opponent attacks in period 2-- but only at low dose

.Neurocrine Biosciences has actually obtained its hoped-for account in a phase 2 schizophrenia test,...